Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 40  Show

Literature citations Results

Wnt4 is a novel biomarker for the early detection of kidney tubular injury after ischemia/reperfusion injury.

Zhao S.L., Wei S.Y., Wang Y.X., Diao T.T., Li J.S., He Y.X., Yu J., Jiang X.Y., Cao Y., Mao X.Y. et al.

Sci Rep 6:32610-32610(2016) · Mapped (5)

Ubiquitin-specific protease 22 acts as an oncoprotein to maintain glioma malignancy through deubiquitinating B cell-specific Moloney murine leukemia virus integration site 1 for stabilization.

Qiu G.Z., Mao X.Y., Ma Y., Gao X.C., Wang Z., Jin M.Z., Sun W., Zou Y.X., Lin J., Fu H.L. et al.

Cancer Sci. 109:2199-2210(2018) · Mapped (4)

Study on the skip metastasis of axillary lymph nodes in breast cancer and their relation with Gli1 expression.

Wang H., Mao X.Y., Zhao T.T., Zheng X.Y., Jin F., Li J.G.

Tumour Biol. 33:1943-1950(2012) · Mapped (4)

SNCA rs356219 variant increases risk of sporadic Parkinson's disease in ethnic Chinese.

Li N.N., Mao X.Y., Chang X.L., Zhao D.M., Zhang J.H., Liao Q., Yu W.J., Tan E.K., Peng R.

Am. J. Med. Genet. B Neuropsychiatr. Genet. 162B:452-456(2013) · Mapped (8)

Silencing of Forkhead box D1 inhibits proliferation and migration in glioma cells.

Gao Y.F., Zhu T., Mao X.Y., Mao C.X., Li L., Yin J.Y., Zhou H.H., Liu Z.Q.

Oncol. Rep. 37:1196-1202(2017) · Mapped (1)

Relationship between abnormality of FHIT gene and EBV infection in gastric cancer.

Xiao Y.P., Han C.B., Mao X.Y., Li J.Y., Xu L., Ren C.S., Xin Y.

World J. Gastroenterol. 11:3212-3216(2005) · Mapped (11)

PRRT2 mutations are related to febrile seizures in epileptic patients.

He Z.W., Qu J., Zhang Y., Mao C.X., Wang Z.B., Mao X.Y., Deng Z.Y., Zhou B.T., Yin J.Y., Long H.Y. et al.

Int J Mol Sci 15:23408-23417(2014) · Mapped (1)

Promoter methylation status and expression of estrogen receptor alpha in familial breast cancer patients.

Wei J., Han B., Mao X.Y., Wei M.J., Yao F., Jin F.

Tumour Biol. 33:413-420(2012) · Mapped (82)

Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma.

Shi Y.X., Zhu T., Zou T., Zhuo W., Chen Y.X., Huang M.S., Zheng W., Wang C.J., Li X., Mao X.Y. et al.

Oncotarget 7:85235-85243(2016) · Mapped (1)

PPIC, EMP3 and CHI3L1 Are Novel Prognostic Markers for High Grade Glioma.

Gao Y.F., Zhu T., Mao C.X., Liu Z.X., Wang Z.B., Mao X.Y., Li L., Yin J.Y., Zhou H.H., Liu Z.Q.

Int J Mol Sci 17:0-0(2016) · Mapped (11)

p53 nuclear accumulation and ERalpha expression in ductal hyperplasia of breast in a cohort of 215 Chinese women.

Mao X.Y., Fan C.F., Zheng H.C., Wei J., Yao F., Jin F.

J. Exp. Clin. Cancer Res. 29:112-112(2010) · Mapped (184)

No association of four candidate genetic variants in MnSOD and SYNIII with Parkinson's disease in two Chinese populations.

Yu W.J., Li N.N., Tan E.K., Cheng L., Zhang J.H., Mao X.Y., Chang X.L., Zhao D.M., Liao Q., Peng R.

PLoS ONE 9:e88050-e88050(2014) · Mapped (21)

Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study.

Tan E.K., Peng R., Teo Y.Y., Tan L.C., Angeles D., Ho P., Chen M.L., Lin C.H., Mao X.Y., Chang X.L. et al.

Hum. Mutat. 31:561-568(2010) · Mapped (5)

MTHFR C677T variant reduces risk of sporadic Parkinson's disease in ethnic Chinese.

Liao Q., Li N.N., Mao X.Y., Chang X.L., Zhao D.M., Zhang J.H., Yu W.J., Tan E.K., Peng R.

Acta Neurol. Scand. 130:e30-4(2014) · Mapped (12)

MTA1 expression correlates significantly with cigarette smoke in non-small cell lung cancer.

Xu L., Mao X.Y., Fan C.F., Zheng H.C.

Virchows Arch. 459:415-422(2011) · Mapped (5)

MCCC1/LAMP3 reduces risk of sporadic Parkinson's disease in Han Chinese.

Li N.N., Tan E.K., Chang X.L., Mao X.Y., Zhao D.M., Zhang J.H., Liao Q., Peng R.

Acta Neurol. Scand. 128:136-139(2013) · Mapped (8)

Lack of evidence for association of a UCH-L1 S18Y polymorphism with Parkinson's disease in a Han-Chinese population.

Zhang Z.J., Burgunder J.M., An X.K., Wu Y., Chen W.J., Zhang J.H., Wang Y.C., Xu Y.M., Gou Y.R., Yuan G.G. et al.

Neurosci. Lett. 442:200-202(2008) · Mapped (5)

Increased N-myc downstream-regulated gene 1 expression is associated with breast atypia-to-carcinoma progression.

Mao X.Y., Fan C.F., Wei J., Liu C., Zheng H.C., Yao F., Jin F.

Tumour Biol. 32:1271-1276(2011) · Mapped (10)

Impacts of EGFR mutation and EGFR-TKIs on incidence of brain metastases in advanced non-squamous NSCLC.

Wang B.X., Ou W., Mao X.Y., Liu Z., Wu H.Q., Wang S.Y.

Clin Neurol Neurosurg 160:96-100(2017) · Mapped (41)

Impact of LPL gene rs283 polymorphism on exercise-induced changes in metabolism of obese adolescents and the regulatory mechanisms behind it.

Gao R.R., Wang M., Hu Y., Xu C.Y., Li Y.C., Zhang Z.Y., Chen S.Y., Mao X.Y.

Exp. Physiol. 100:698-707(2015) · Mapped (10)

Huperzine A ameliorates cognitive deficits in streptozotocin-induced diabetic rats.

Mao X.Y., Cao D.F., Li X., Yin J.Y., Wang Z.B., Zhang Y., Mao C.X., Zhou H.H., Liu Z.Q.

Int J Mol Sci 15:7667-7683(2014) · Mapped (3)

GWAS-linked GAK locus in Parkinson's disease in Han Chinese and meta-analysis.

Li N.N., Chang X.L., Mao X.Y., Zhang J.H., Zhao D.M., Tan E.K., Peng R.

Hum. Genet. 131:1089-1093(2012) · Mapped (10)

GSK3beta reduces risk of sporadic Parkinson's disease in ethnic Chinese.

Zhao D.M., Li N.N., Zhang J.H., Chang X.L., Mao X.Y., Liao Q., Tan E.K., Peng R.

Am. J. Med. Genet. B Neuropsychiatr. Genet. 159B:718-721(2012) · Mapped (4)

Genome-scale analysis identifies GJB2 and ERO1LB as prognosis markers in patients with pancreatic cancer.

Zhu T., Gao Y.F., Chen Y.X., Wang Z.B., Yin J.Y., Mao X.Y., Li X., Zhang W., Zhou H.H., Liu Z.Q.

Oncotarget 8:21281-21289(2017) · Mapped (15)

Gene-wide tagging study of the association between KCNT1 polymorphisms and the susceptibility and efficacy of genetic generalized epilepsy in Chinese population.

Qu J., Zhang Y., Yang Z.Q., Mao X.Y., Zhou B.T., Yin J.Y., He H., Li X.P., Long H.Y., Lv N. et al.

CNS Neurosci Ther 20:140-146(2014) · Mapped (3)

1 to 25 of 40  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again